Summerset Group Holdings Ltd (ASX:SNZ) profit up 26%

Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30 2018 will rise

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

New Zealand retirement home and hospital group Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30, 2018, will be up between 21% and 26% on the previous corresponding period.

According to an earnings guidance announcement today, Summerset will report underlying profit of between NZ$43 million and NZ$45 million for the period off the back of "strong development margins" on settled homes over the first half.

Sales and resales volumes are also on track with full financial results to be handed down on August 14.

On home soil companies intending to cash in on the ageing population include Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) which has been having a tough time of late as its share price tumbled to multi-year lows off the back of challenging industry dynamics and private health insurance declines.

Goldman Sachs placed a sell rating on Ramsay earlier this month, but many investors keen on its growth prospects in the private hospital sector might see it as hovering in buy territory.

Healthscope Ltd (ASX: HSO) shares have also tumbled into the red of late, down 0.2% to $2.24 at the time of writing.

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

three excited doctors with hands in the air
Healthcare Shares

Why Macquarie forecasts a 22% upside for this ASX All Ords healthcare stock

Macquarie expects a big rebound ahead for this ASX healthcare stock. But why?

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Healthcare Shares

Guess which ASX All Ords stock is jumping 9% on $1.6b market opportunity

This small cap is having a big day. But why?

Read more »

A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
Healthcare Shares

75% upside: Broker tips two ASX healthcare shares

This broker sees big potential in these two Australian healthcare companies 

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

What does the Macquarie Hospital Claims Index mean for ASX 200 health insurance stocks?

Macquarie shares its view on Medibank Private and NIB Holdings.

Read more »

Two lab workers fist pump each other.
Broker Notes

What's JP Morgan's price target on CSL shares?

Are CSL shares undervalued or will they continue to underperform?

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

2 ASX healthcare stocks making huge moves on big news

These shares are getting investors excited today. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Which ASX All Ords stock is up 15% on guidance upgrade?

Let's find out what is getting investors excited on Tuesday.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

3 reasons why the Sigma Healthcare share price could be a buy

This business has a very exciting outlook.

Read more »